In addition, compared to normal tissues, higher SEPT5 expression was observed in breast invasive carcinoma, cholangiocarcinoma, liver hepatocellular carcinoma, and lung squamous cell carcinoma, among others. This evidence concerns the gene SEPTIN5 and cholangiocarcinoma.